scispace - formally typeset
A

Ajit Varki

Researcher at University of California, San Diego

Publications -  557
Citations -  63836

Ajit Varki is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Sialic acid & SIGLEC. The author has an hindex of 124, co-authored 542 publications receiving 58772 citations. Previous affiliations of Ajit Varki include Emory University & National Institute of Advanced Industrial Science and Technology.

Papers
More filters
Journal ArticleDOI

Canine and feline parvoviruses preferentially recognize the non-human cell surface sialic acid N-glycolylneuraminic acid

TL;DR: The conserved Neu5Gc-binding preference of these viruses likely plays a role in the natural history of the virus in vivo, and transcripts of CMAH are at very low levels in Western dog breed cells.
Journal ArticleDOI

O-Acetylation of sialic acid on Group B Streptococcus inhibits neutrophil suppression and virulence.

TL;DR: Serotype-specific patterns of GBS Sia O-acetylation that can be manipulated by genetic and biochemical means are described and it is demonstrated that this subtle modification attenuates Gbs Sia-mediated neutrophil suppression and animal virulence.
Book ChapterDOI

Steps in the phosphorylation of the high mannose oligosaccharides of lysosomal enzymes.

TL;DR: It is proposed that the first enzyme in this scheme, N-acetylglucosaminylphosphotransferase, catalyses the initial, determining step by which newly synthesized acid hydrolases are distinguished from other newly synthesised glycoproteins and thus are eventually targeted to lysosomes.
Journal ArticleDOI

Loss of CMAH during Human Evolution Primed the Monocyte-Macrophage Lineage toward a More Inflammatory and Phagocytic State.

TL;DR: In innate immune responses in Cmah−/− mice are studied, emulating human loss of the gene encoding production of Neu5Gc, a major cell surface sialic acid, which likely had complex effects on immunity, providing greater capabilities to clear sublethal bacterial challenges, possibly at the cost of endotoxic shock risk.